Tower Research Capital LLC (Trc) Burning Rock Biotech LTD Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.91 - $2.29 $614 - $1,545	-675 Reduced 79.51%	174 $0
Q2 2023 Aug 14, 2023	BUY	$2.15 - $3.16 $1,825 - $2,682	849 New	849 $1,000
Q4 2022 Feb 10, 2023	BUY	$1.73 - $2.95 $12,082 - $20,602	6,984 Added 129.6%	12,373 $28,000
Q3 2022 Nov 10, 2022	SELL	$2.39 - $3.96 $812 - $1,346	-340 Reduced 5.93%	5,389 $13,000
Q2 2022 Aug 15, 2022	BUY	$1.75 - $10.44 $5,747 - $34,284	3,284 Added 134.31%	5,729 $16,000
Q1 2022 May 12, 2022	BUY	$6.7 - $10.23 $14,827 - $22,638	2,213 Added 953.88%	2,445 $23,000
Q4 2021 Feb 14, 2022	BUY	$9.43 - $17.14 $2,187 - $3,976	232 New	232 $2,000
Q3 2021 Nov 15, 2021	SELL	$17.37 - $27.92 $1,163 - $1,870	-67 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $1,751 - $2,509	67 New	67 $2,000

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $642M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.